Concepedia

Linglong Yin

LY

12

Publications

626

Citations

12

H-Index

2017

Active since

Affiliations

Central South University(Current)

Xiangya Hospital Central South University

Guangdong Pharmaceutical University

Third Xiangya Hospital

First Affiliated Hospital of Guangdong Pharmaceutical University

Linglong Yin is an author at Central South University specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2023

12

Publications

12

The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells

Youxiang Hou, Qianling Zhu, Zheng Li et al. · Cell Death and Disease · 2017 · 127 citations · Full text

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells

Linglong Yin, Youhong Liu, Yuchong Peng et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 121 citations · Full text

UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications

Yingxue Gao, Yijun Liu, Youhong Liu et al. · Cancer Letters · 2021 · 74 citations

, , +6

Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition

Xiaohui Yu, Youhong Liu, Linglong Yin et al. · Oncogene · 2018 · 62 citations · Full text

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

Bowen Yuan, Youhong Liu, Xiaohui Yu et al. · Cell Death and Disease · 2018 · 57 citations · Full text

Rows per page

1–5 of 12